翰宇药业：公司的利拉鲁肽注射液除了在美国市场销售，还与合作伙伴积极拓展包括欧洲、中东、东南亚等市场

Group 1 - The company has expanded the market for its liraglutide injection beyond the United States, actively exploring over 30 countries and regions including Europe, the Middle East, and Southeast Asia [2] - The frequency of shipments is not fixed but is dynamically arranged based on rolling sales forecasts and production plans developed in collaboration with global customers [2]